154 related articles for article (PubMed ID: 38422655)
1. Targeting Nrf2 to treat thyroid cancer.
Gong Z; Xue L; Li H; Fan S; van Hasselt CA; Li D; Zeng X; Tong MCF; Chen GG
Biomed Pharmacother; 2024 Apr; 173():116324. PubMed ID: 38422655
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers.
Lin L; Wu Q; Lu F; Lei J; Zhou Y; Liu Y; Zhu N; Yu Y; Ning Z; She T; Hu M
Front Oncol; 2023; 13():1184079. PubMed ID: 37810967
[TBL] [Abstract][Full Text] [Related]
3. The role of Nrf2 and PPARgamma in the improvement of oxidative stress in hypertension and cardiovascular diseases.
Dovinova I; Kvandová M; Balis P; Gresova L; Majzunova M; Horakova L; Chan JY; Barancik M
Physiol Res; 2020 Dec; 69(Suppl 4):S541-S553. PubMed ID: 33656904
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress.
Zhang S; Duan S; Xie Z; Bao W; Xu B; Yang W; Zhou L
Front Pharmacol; 2022; 13():924817. PubMed ID: 35754474
[TBL] [Abstract][Full Text] [Related]
5. NFE2-Related Transcription Factor 2 Coordinates Antioxidant Defense with Thyroglobulin Production and Iodination in the Thyroid Gland.
Ziros PG; Habeos IG; Chartoumpekis DV; Ntalampyra E; Somm E; Renaud CO; Bongiovanni M; Trougakos IP; Yamamoto M; Kensler TW; Santisteban P; Carrasco N; Ris-Stalpers C; Amendola E; Liao XH; Rossich L; Thomasz L; Juvenal GJ; Refetoff S; Sykiotis GP
Thyroid; 2018 Jun; 28(6):780-798. PubMed ID: 29742982
[TBL] [Abstract][Full Text] [Related]
6. The Keap1/Nrf2 Signaling Pathway in the Thyroid-2020 Update.
Thanas C; Ziros PG; Chartoumpekis DV; Renaud CO; Sykiotis GP
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33158045
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 is commonly activated in papillary thyroid carcinoma, and it controls antioxidant transcriptional responses and viability of cancer cells.
Ziros PG; Manolakou SD; Habeos IG; Lilis I; Chartoumpekis DV; Koika V; Soares P; Kyriazopoulou VE; Scopa CD; Papachristou DJ; Sykiotis GP
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1422-7. PubMed ID: 23766517
[TBL] [Abstract][Full Text] [Related]
8. Keap1/Nrf2 Signaling: A New Player in Thyroid Pathophysiology and Thyroid Cancer.
Renaud CO; Ziros PG; Chartoumpekis DV; Bongiovanni M; Sykiotis GP
Front Endocrinol (Lausanne); 2019; 10():510. PubMed ID: 31428048
[TBL] [Abstract][Full Text] [Related]
9. Nrf2-Mediated Antioxidant Defense and Thyroid Hormone Signaling: A Focus on Cardioprotective Effects.
Sabatino L
Antioxidants (Basel); 2023 May; 12(6):. PubMed ID: 37371907
[TBL] [Abstract][Full Text] [Related]
10. Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer.
Tsai HY; Bronner MP; March JK; Valentine JF; Shroyer NF; Lai LA; Brentnall TA; Pan S; Chen R
Cancer Lett; 2022 Nov; 549():215915. PubMed ID: 36113636
[TBL] [Abstract][Full Text] [Related]
11. Potential Applications of NRF2 Modulators in Cancer Therapy.
Panieri E; Buha A; Telkoparan-Akillilar P; Cevik D; Kouretas D; Veskoukis A; Skaperda Z; Tsatsakis A; Wallace D; Suzen S; Saso L
Antioxidants (Basel); 2020 Feb; 9(3):. PubMed ID: 32106613
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Early Biological Effects of Isoprene-Derived Particulate Matter Enhanced by Anthropogenic Pollutants.
Surratt JD; Lin YH; Arashiro M; Vizuete WG; Zhang Z; Gold A; Jaspers I; Fry RC
Res Rep Health Eff Inst; 2019 Mar; 2019(198):1-54. PubMed ID: 31872748
[TBL] [Abstract][Full Text] [Related]
13. Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?
Wang R; Liang L; Matsumoto M; Iwata K; Umemura A; He F
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830722
[TBL] [Abstract][Full Text] [Related]
14. NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer.
Zhang TT; Qu N; Sun GH; Zhang L; Wang YJ; Mu XM; Wei WJ; Wang YL; Wang Y; Ji QH; Zhu YX; Shi RL
Int J Oncol; 2018 Aug; 53(2):685-693. PubMed ID: 29901070
[TBL] [Abstract][Full Text] [Related]
15. Ameliorative inhibition of sirtuin 6 by imidazole derivative triggers oxidative stress-mediated apoptosis associated with Nrf2/Keap1 signaling in non-small cell lung cancer cell lines.
Dindi UMR; Al-Ghamdi S; Alrudian NA; Dayel SB; Abuderman AA; Saad Alqahtani M; Bahakim NO; Ramesh T; Vilwanathan R
Front Pharmacol; 2023; 14():1335305. PubMed ID: 38235110
[No Abstract] [Full Text] [Related]
16. Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells.
Zhang L; Zhang J; Jin Y; Yao G; Zhao H; Qiao P; Wu S
Front Cell Dev Biol; 2021; 9():728172. PubMed ID: 34589492
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma.
Iseda N; Itoh S; Toshida K; Tomiyama T; Morinaga A; Shimokawa M; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Yoshizumi T; Mori M
Cancer Sci; 2022 Jul; 113(7):2272-2287. PubMed ID: 35466502
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of Nrf2 inducers in chronic pain: Evidence from preclinical studies.
Zhou YQ; Mei W; Tian XB; Tian YK; Liu DQ; Ye DW
Pharmacol Ther; 2021 Sep; 225():107846. PubMed ID: 33819559
[TBL] [Abstract][Full Text] [Related]
20. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance.
Payandeh Z; Pirpour Tazehkand A; Barati G; Pouremamali F; Kahroba H; Baradaran B; Samadi N
Biochimie; 2020 Dec; 179():32-45. PubMed ID: 32946993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
